Immunization, Hib3 (% of children ages 12-23 months) in Syria
Syria: Immunization, Hib3 (% of children ages 12-23 months) was 73.0% in 2024. ▼ Falling
Immunization, Hib3 in Syria, 2001–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Syria recorded 73.0% for immunization, hib3 in 2024.
The figure is up 10.6% on the previous year and up 30.4% over ten years.
Over the whole period, immunization, hib3 in Syria peaked at 84.0% in 2001 and was at its lowest, 54.0%, in 2013.
Syria ranks 157th of 191 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 24 years of available data.
Immunization, Hib3 (% of children ages 12-23 months) in Syria, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2001 | 84.0% | — |
| 2002 | 83.0% | -1.2% |
| 2003 | 82.0% | -1.2% |
| 2004 | 81.0% | -1.2% |
| 2005 | 80.0% | -1.2% |
| 2006 | 80.0% | +0.0% |
| 2007 | 80.0% | +0.0% |
| 2008 | 79.0% | -1.2% |
| 2009 | 80.0% | +1.3% |
| 2010 | 80.0% | +0.0% |
| 2011 | 72.0% | -10.0% |
| 2012 | 58.0% | -19.4% |
| 2013 | 54.0% | -6.9% |
| 2014 | 56.0% | +3.7% |
| 2015 | 54.0% | -3.6% |
| 2016 | 55.0% | +1.9% |
| 2017 | 61.0% | +10.9% |
| 2018 | 60.0% | -1.6% |
| 2019 | 67.0% | +11.7% |
| 2020 | 62.0% | -7.5% |
| 2021 | 61.0% | -1.6% |
| 2022 | 59.0% | -3.3% |
| 2023 | 66.0% | +11.9% |
| 2024 | 73.0% | +10.6% |
Syria compared with similar countries
- Syria's 73.0% is above the median for low income countries, which is 73.0%, 1.0× the median. (25 countries reporting)
- Syria's 73.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 96.0%, 76% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.0% | 79.0% | 84.0% | 9 |
| 2010s | 61.7% | 54.0% | 80.0% | 10 |
| 2020s | 64.2% | 59.0% | 73.0% | 5 |
Countries ranked near Syria
- 156 South Africa 74.0% compare
- 157 Ethiopia 73.0% compare
- 157 South Sudan 73.0% compare
- 160 Marshall Islands 72.0% compare
- 160 Panama 72.0% compare
More health data for Syria
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Un projection of annual infant deaths 1,491 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, male, per capita 0.0528 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Syria?
- Immunization, hib3 in Syria was 73.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Syria?
- The highest recorded value was 84.0% in 2001.
- What is the lowest immunization, hib3 recorded in Syria?
- The lowest recorded value was 54.0% in 2013.
- How does Syria rank for immunization, hib3?
- Syria ranks 157th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Syria?
- Over the last ten years it is up 30.4%. The long-run trend across the full record is falling.
- Where does this Syria data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.